0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
69.45%
Revenue growth above 1.5x 3606.HK's 8.40%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
283.79%
Gross profit growth above 1.5x 3606.HK's 12.15%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
229.63%
Positive EBIT growth while 3606.HK is negative. John Neff might see a substantial edge in operational management.
229.63%
Operating income growth above 1.5x 3606.HK's 34.59%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
183.19%
Net income growth above 1.5x 3606.HK's 15.67%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
171.60%
EPS growth above 1.5x 3606.HK's 16.13%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
171.60%
Diluted EPS growth above 1.5x 3606.HK's 16.13%. David Dodd would see if there's a robust moat protecting these shareholder gains.
16.23%
Share count expansion well above 3606.HK's 1.27%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
16.16%
Diluted share change of 16.16% while 3606.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-5.02%
Negative OCF growth while 3606.HK is at 48.64%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-3.95%
Negative FCF growth while 3606.HK is at 55.60%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-25.20%
Negative 10Y revenue/share CAGR while 3606.HK stands at 107.59%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-14.92%
Negative 5Y CAGR while 3606.HK stands at 58.41%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
78.46%
3Y revenue/share CAGR above 1.5x 3606.HK's 14.48%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-879.87%
Negative 10Y OCF/share CAGR while 3606.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-38.06%
Negative 5Y OCF/share CAGR while 3606.HK is at 206.83%. Joel Greenblatt would question the firm’s operational model or cost structure.
-2020.15%
Negative 3Y OCF/share CAGR while 3606.HK stands at 36.88%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
618.94%
Net income/share CAGR above 1.5x 3606.HK's 54.17% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
82.63%
5Y net income/share CAGR above 1.5x 3606.HK's 16.28%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
135.49%
Positive short-term CAGR while 3606.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
109.13%
10Y equity/share CAGR at 50-75% of 3606.HK's 203.98%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
-16.14%
Negative 5Y equity/share growth while 3606.HK is at 31.89%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
41.33%
3Y equity/share CAGR above 1.5x 3606.HK's 12.83%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-91.69%
Cut dividends over 10 years while 3606.HK stands at 48.55%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.95%
AR growth well above 3606.HK's 3.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
-33.37%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-10.25%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.50%
We have a declining book value while 3606.HK shows 1.55%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-55.61%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.41%
Our R&D shrinks while 3606.HK invests at 11.63%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
71.83%
We expand SG&A while 3606.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.